Anixa Biosciences (ANIX) announced that its Board of Directors has approved the purchase of Bitcoin as a treasury reserve asset. With Anixa’s strong balance sheet and excess cash, this strategic decision aims to diversify the company’s treasury holdings while positioning Anixa to benefit from the potential long-term value of digital assets. The company also reaffirmed its ongoing stock buyback program as part of its commitment to enhancing shareholder value.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANIX:
- Anixa Biosciences initiates third cohort in CAR-T clinical trial
- Anixa Biosciences Reports Promising Phase 1 Vaccine Results
- Anixa Biosciences announces second dose administered in ovarian cancer trial
- Anixa Biosciences announces submission of protocol amendment for CAR-T trial
- Anixa Biosciences announces Phase 2 study for breast cancer vaccine
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue